<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SPI-27580</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Dishman India</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Dishman Pharmaceuticals and Chemicals Limited (Dishman or the Company), incorporated in 1983, is one of the leading companies in India providing contract research and contract manufacturing services. Over the next three years, Dishman is undertaking an investment program (the Project) including the construction of new facilities at its existing manufacturing site in India, the establishment of a greenfield manufacturing facility in China and investments in overseas subsidiaries and joint ventures.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">The anticipated development impact of the project is as follows:     - south-south investment of an Indian company into China and transfer of knowhow for USFDS-approvable standards;    - lower the overall costs of medicines R&amp;D and manufacturing for customers thus facilitating a more affordable end price of medicines for consumers;    - technology transfer to Dishman from its global pharmaceutical market clients and from Dishman of its knowhow in API manufacturing to its joint-venture partners; and    - a demonstration effect for others in the sector through Dishmans commitment to intellectual property rights and adherence to Indian environmental performance and labor standards.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">DISHMAN PHARMACEUTICALS AND CHEMICALS LIMITED</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SPI-27580" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2009-04-06" type="1"></activity-date>
  <activity-date iso-date="2009-07-17" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Mr. Deepak Pandya, Company Secretary and Head (Legal) Dishman Pharmaceuticals and Chemicals Limited, Bhadr-Raj Chambers,    Swastik Cross Roads, Navrangapura,   Ahmedabad  380009, India    Telephone: +91 (0) 79 2644 3053/ +91 (0) 79 2644 5807 Fax: +91 (0) 79 2642 098    Email: Deepak@dishmangroup.com Website:  http://www.dishmangroup.com/</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN"></narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="IN" percentage="100">
   <narrative xml:lang="EN">India</narrative>
  </recipient-country>
  <location ref="IN-India">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The project involves the construction of new facilities at its existing manufacturing site in Bavla, India, the construction of a greenfield manufacturing facility in Shanghai, China, and additional investments in existing subsidiaries and joint ventures including Saudi Arabia.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>22.0000000000 79.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">FA - Pharmaceuticals and Medicine</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $15.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2009-04-06"></period-start>
   <period-end iso-date="2009-06-30"></period-end>
   <value currency="USD" value-date="2009-04-06">15000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2009-04-06"></transaction-date>
   <value currency="USD" value-date="2009-04-06">15000000</value>
   <receiver-org>
    <narrative xml:lang="EN">DISHMAN PHARMACEUTICALS AND CHEMICALS LIMITED</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SPI/27580/dishman-india">
   <title>
    <narrative xml:lang="EN">Summary of Project Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
